HEAD AND NECK SQUAMOUS CELL CARCINOMA
Clinical trials for HEAD AND NECK SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New targeted drug shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called LY4052031 in people with advanced or metastatic solid tumors, including bladder, breast, lung, and other cancers. The drug is designed to target and attack cancer cells while sparing healthy ones. The trial has two parts: first to find the safes…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 29, 2026 01:37 UTC
-
New hope for Hard-to-Treat cancers? early trial launches
Disease control Recruiting nowThis early-phase study tests a new drug called DR-0202 in people with advanced solid tumors (like breast, lung, or pancreatic cancer) that have not responded to at least two prior treatments. The main goals are to check the drug's safety and find the best dose. About 96 participa…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Dren Bio • Aim: Disease control
Last updated Apr 29, 2026 01:36 UTC
-
New hope for head and neck cancer patients who stopped responding to standard treatments
Disease control Recruiting nowThis study tests a new drug called SIBP-03 combined with cetuximab in people with advanced head and neck cancer that has come back or spread. Participants must have already tried immunotherapy and platinum chemotherapy without success. The goal is to see if the combination can sh…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Shanghai Institute Of Biological Products • Aim: Disease control
Last updated Apr 29, 2026 01:36 UTC
-
Second-Chance radiation cocktail targets returned head and neck cancer
Disease control Recruiting nowThis study is for people whose head and neck cancer has returned after previous treatment. It tests a combination of two drugs (tislelizumab and pamiparib) plus chemotherapy and a second round of radiation. The goal is to find the safest dose and see if this approach can control …
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Apr 29, 2026 01:34 UTC
-
New cocktail of cancer drugs could shrink head and neck tumors
Disease control Recruiting nowThis study tests whether combining three different medicines can shrink tumors in adults with head and neck cancer that has spread or come back. Participants are split into three groups, each receiving a different mix of the drugs as infusions. The goal is to see if the combinati…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
New targeted therapy TER-2013 enters trials for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental drug called TER-2013 in people with advanced solid tumors (like breast, endometrial, ovarian, lung, head and neck, esophageal, or cervical cancer) that have specific genetic changes in the AKT/PI3K/PTEN pathway. The trial has two phases: first, fi…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Terremoto Biosciences Inc. • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
New combo therapy aims to improve survival in head and neck cancer
Disease control Recruiting nowThis study tests whether adding petosemtamab to the standard immunotherapy pembrolizumab helps people with advanced head and neck cancer live longer. About 700 adults whose cancer has spread or returned and whose tumors have a specific marker (PD-L1) will be randomly assigned to …
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Merus B.V. • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests an experimental drug called VMD-928, taken as a pill, either alone or with pembrolizumab (an immunotherapy). It is for adults with advanced solid tumors or lymphoma that have stopped responding to standard treatments. The goal is to find the safest dose and see i…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: VM Oncology, LLC • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
Fat flap may ease neck pain and swallowing trouble after cancer therapy
Symptom relief Recruiting nowThis study tests whether a buried fat flap procedure is safe and helpful for people who have neck problems like pain, stiffness, swelling, or trouble swallowing after radiation and surgery for head and neck cancer. About 12 adults who need a salvage neck dissection will receive t…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Apr 29, 2026 01:36 UTC
-
New study tests safer pain relief for cancer patients
Symptom relief Recruiting nowThis study tests whether a high dose of gabapentin, a non-opioid pain medicine, can prevent the need for opioid painkillers in people with head and neck cancer who get chemotherapy and radiation. Mouth sores from treatment can be very painful, and opioids have serious side effect…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Symptom relief
Last updated Apr 29, 2026 01:36 UTC
-
Can a constipation drug help head and neck cancer patients before surgery?
Symptom relief Recruiting nowThis pilot study is testing whether methylnaltrexone, a drug used for constipation, can be safely given to people with oral cavity squamous cell carcinoma for two weeks before their surgery. The main goal is to check for side effects. About 25 adults whose cancer can be removed b…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE4 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Apr 28, 2026 13:01 UTC
-
Remote hearing checks could save cancer Patients' hearing
Knowledge-focused Recruiting nowThis study looks at whether offering hearing tests close to home or remotely helps more head and neck cancer patients get their hearing checked during treatment. Many patients on cisplatin chemotherapy or radiation near the ear can lose hearing, but regular monitoring can catch c…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Apr 29, 2026 01:36 UTC
-
New program aims to speed up Post-Surgery radiation for head and neck cancer patients
Knowledge-focused Recruiting nowThis study tests a program called ENDURE that helps head and neck cancer patients start radiation therapy within 6 weeks after surgery, as guidelines recommend. About 532 adults will be assigned to either the navigation program or usual care to see which leads to more timely trea…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Knowledge-focused
Last updated Apr 28, 2026 13:02 UTC